Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-18
1999-09-28
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548469, A01N 4338
Patent
active
059589647
ABSTRACT:
The present invention is directed to a method of preventing cytotoxic effects of amyloid beta protein on cells. The method comprises exposing the cells to an effective amount of melatonin. The invention further provides a method of treating Alzheimer's disease in a human subject, which comprises administering an amount of melatonin effective to prevent the cytotoxic effects of amyloid beta protein to the human subject.
REFERENCES:
patent: 5449690 (1995-09-01), Lesieur et al.
patent: 5464872 (1995-11-01), Langlois et al.
patent: 5470846 (1995-11-01), Sandyk
patent: 5541228 (1996-07-01), Takaki et al.
patent: 5552418 (1996-09-01), Depreux et al.
patent: 5552428 (1996-09-01), Fraschini et al.
patent: 5554642 (1996-09-01), Langolis et al.
patent: 5580878 (1996-12-01), D'Orlando et al.
patent: 5591775 (1997-01-01), Depreux et al.
patent: 5596019 (1997-01-01), Mattson et al.
patent: 5707652 (1998-01-01), Lewy
Mishima, K. et al., Acta Psychiat Scand 89:1-7 (1994).
Huerto-Delgadillo, L., et al., J Pineal Res 17:55-62 (1994).
Dori, D., et al., Chronobiol 21:121-126 (1994).
Iguchi, H., et al., J Clin Endocrinol Metabol 55:27-29 (1982).
Pappolla, M.A., et al., Mol Chem Neuropathol 28:21-34 (1996).
Pieraoli, W., Aging 3 (2):99-101 (1991).
Pierpaoli, W., et al., Ann NY Acad Sci 621:291-313 (1991).
Reiter, R.J., Exp Gerontol 30:199-212 (1995).
Skene, D.J., et al., Brain Research 528:170-174 (1990).
Souetre, E., et al., Am J Psychiatry 146:1037-1040 (1989).
Mattson, M.P., Ann NY Acad Sci 747:50-76 (1994).
Hensley, K., et al., Proc Natl Acad Sci USA 91(8):3270-3274 (1994).
Pappolla, J. Neurosci. 17, 1683, 1997.
Lukton David
South Alabama Medical Science Foundation
Tsang Cecilia J.
LandOfFree
Use of melatonin to prevent cytotoxic effects of amyloid beta pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of melatonin to prevent cytotoxic effects of amyloid beta pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of melatonin to prevent cytotoxic effects of amyloid beta pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-703856